Table 2.
Uni-Variable Logistic Regression Analysis Evaluating Risk Factors for Ocular Disease in a Cohort of Individuals with Sarcoidosis
| Variables | Odds Ratio | p-value | 95% Confidence Interval |
|---|---|---|---|
| Age | 1.01 | 0.82 | 0.96 −1.06 |
| Gender (F/M) | 2.11 | 0.23 | 0.62–7.20 |
| Race (B/W) | 1.26 | 0.71 | 0.37–4.36 |
| Ethnicity (H/NH) | 1.34 | 0.59 | 0.46–3.94 |
| Pulmonary (Y/N) | 0.51 | 0.31 | 0.14–1.84 |
| Skin (Y/N) | 0.38 | 0.36 | 0.05–3.07 |
| ENT (Y/N) | 7.67 | 0.05 | 0.99–59.57 |
| Adrenal (Y/N) | 1 | 0 | 0 |
| Cardiac (Y/N) | 0.95 | 0.95 | 0.19–4.72 |
| CNS (Y/N) | 6.14 | 0.03* | 1.21–31.09 |
| GI (Y/N) | 0.95 | 0.95 | 0.19–4.72 |
| Cancer (Y/N) | 1.15 | 0.84 | 0.29–4.56 |
| CD4 Count Baseline | 1 | 0.62 | 0.999–1.002 |
| CD4 Count 3 months | 1 | 0.97 | 0.995–1.005 |
| IL-2R Baseline | 1 | 0.25 | 0.997–1.001 |
| Lysozyme Baseline | 0.94 | 0.58 | 0.75–1.18 |
| ACE Baseline | 1.01 | 0.46 | 0.99–1.02 |
| CRP Baseline | 0.64 | 0.22 | 0.31–1.31 |
Abbreviations: F, female; M, male; B, Black; W, White; H, Hispanic; NH, Non-Hispanic; Y, yes; N, no; ENT, ear nose and throat; CNS, central nervous system; GI, gastrointestinal; IL, interleukin; ACE, angiotensin converting enzyme; CRP, C-Reactive protein.